Biochemical and functional interaction between ZNF224 and ZNF255, two members of the Krüppel-like zinc-finger protein family and WT1 protein isoforms

Human Molecular Genetics

Volumn 19, Issue 18, 2010, Pages 3544-3556

  Florio, Francesca ^a,c   Cesaro, Elena ^a   Montano, Giorgia ^a   Izzo, Paola ^a   Miles, Colin ^b   Costanzo, Paola ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR; RNA; UNCLASSIFIED DRUG; WT1 PROTEIN; ZNF224 PROTEIN; ZNF225 PROTEIN;

ANIMAL CELL; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; INTRACELLULAR SPACE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN VARIANT; RNA PROCESSING; TRANSCRIPTION INITIATION;

CELL LINE; HUMANS; PROTEIN BINDING; PROTEIN ISOFORMS; REPRESSOR PROTEINS; TRANSCRIPTIONAL ACTIVATION; WILMS TUMOR; WT1 PROTEINS;

EID: 77956098144     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq270     Document Type: Article

References (51)

1. Emerson, R.O. and Thomas, J.H. (2009) Adaptive evolution in zinc finger transcription factors. PLoS Genet., 5, 1-12.
2. Medugno, L., Costanzo, P., Lupo, A., Monti, M., Florio, F., Pucci, P. and Izzo, P. (2003) A novel zinc finger transcriptional repressor, ZNF224, interacts with the negative regulatory element (AldA-NRE) and inhibits gene expression. FEBS Lett., 534, 93-100.
3. Medugno, L., Florio, F., De Cegli, R., Grosso, M., Lupo, A., Costanzo, P. and Izzo, P. (2005) The Krüppel-like zinc-finger protein ZNF224 represses aldolase A gene transcription by interacting with the KAP1 co-repressor protein. Gene, 329, 35-43.
4. Medugno, L., Florio, F., Cesaro, E., Grosso, M., Lupo, A., Izzo, P. and Costanzo, P. (2007) Differential expression and cellular localization of ZNF224 and ZNF255, two isoforms of the Krüppel-like zinc-finger protein family. Gene, 403, 125-131.
5. Lee, T.H., Lwu, S., Kim, J. and Pelletier, J. (2002) Inhibition of Wilms tumor 1 transactivation by bone marrow zinc finger 2, a novel transcriptional repressor. J. Biol. Chem., 277, 44826-44837.
6. Sun, L., Gu, S., Li, N., Zheng, D., Sun, Y., Li, D., Ji, C., Ying, K., Xie, Y. and Mao, Y. (2005) A novel zinc finger gene ZNF468 with two co-expressional splice variants, ZNF468.1 and ZNF468.2. Biochem. Genet., 43, 271-286.
7. Cheng, Y., Wang, Y., Li, Y., Deng, Y., Hu, J., Mo, X., Li, N., Li, Y., Luo, N., Yuan, W. et al. (2006) A novel human gene ZNF415 with five isoforms inhibits AP-1 and p53-mediated transcriptional activity. Biochem. Biophys. Res.Commun., 351, 33-39.
8. Little, M.H., Prosser, J., Condie, A., Smith, P.J., Van Heyningen, V. and Hastie, N.D. (1992) Zinc finger point mutations within the WT1 gene in Wilms tumor patients. Proc. Natl Acad. Sci. USA, 89, 4791-4795.
9. Scholz, H. and Kirschner, K.M. (2005) A role for the Wilms' tumor protein WT1 in organ development. Physiology (Bethesda), 20, 54-59.
10. Hohenstein, P. and Hastie, N.D. (2006) The many facets of the Wilms' tumour gene, WT1. Hum. Mol. Genet., 15, R196-R201.
11. Haber, D.A., Sohn, R.L., Buckler, A.J., Pelletier, J., Call, K.M. and Housman, D.E. (1991) Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc. Natl Acad. Sci. USA, 88, 9618-9622.
12. Lee, S.B. and Haber, D.A. (2001) Wilms tumor and the WT1 gene. Exp. Cell Res., 264, 74-99.
13. Miles, C.G., Slight, J., Spraggon, L., O'Sullivan, M., Patek, C. and Hastie, N.D. (2003) Mice lacking the 68-amino-acid, mammal-specific N-terminal extension of WT1 develop normally and are fertile. Mol. Cell. Biol., 23, 2608-2613.
14. Natoli, T.A., McDonald, A., Alberta, J.A., Taglienti, M.E., Housman, D.E. and Kreidberg, J.A. (2002) A mammal-specific exon of WT1 is not required for development or fertility. Mol. Cell. Biol., 22, 4433-4438.
15. Hammes, A., Guo, J.K., Lutsch, G., Leheste, J.R., Landrock, D., Ziegler, U., Gubler, M.C. and Schedl, A. (2001) Two splice variants of the Wilms' Tumor 1 gene have distinct functions during sex determination and nephron formation. Cell, 106, 319-329.
16. Barbaux, S., Niaudet, P., Gubler, M.C., Grünfeld, J.P., Jaubert, F., Kuttenn, F., Fékété, C.N., Souleyreau-Therville, N., Thibaud, E., Fellous, M. and McElreavey, K. (1997) Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat. Genet., 17, 467-470.
17. Larsson, S.H., Charlieu, J.P., Miyagawa, K., Engelkamp, D., Rassoulzadegan, M., Ross, A., Cuzin, F., van Heyningen, V. and Hastie, N.D. (1995) Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell, 81, 391-401.
18. Nakagama, H., Heinrich, G., Pelletier, J. and Housman, D.E. (1995) Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product. Mol. Cell. Biol., 15, 1489-1498.
19. Roberts, S.G.E. (2006) The modulation of WTI transcription function by cofactors. Biochem. Soc. Symp., 73, 191-201.
20. Palmer, R.E., Kotsianti, A., Cadman, B., Boyd, T., Gerald, W. and Haber, D.A. (2001) WT1 regulates the expression of the major glomerular podocyte membrane protein Podocalyxin. Curr. Biol., 11, 1805-1809.
21. Maurer, U., Jehan, F., Englert, C., Hubinger, G., Weidmann, E., DeLuca, H.F. and Bergmann, L. (2001) The Wilms' tumor gene product (WT1) modulates the response to 1,25-dihydroxyvitamin D3 by induction of the vitamin D receptor. J. Biol. Chem., 276, 3727-3732.
22. Mayo, M.W., Wang, C.Y., Drouin, S.S., Madrid, L.V., Marshall, A.F., Reed, J.C., Weissman, B.E. and Baldwin, A.S. (1999) WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene. EMBO J., 18, 3990-4003.
23. Morrison, D.J., English, M.A. and Licht, J.D. (2005) WT1 induces apoptosis through transcriptional regulation of the proapoptotic Bcl-2 family member Bak. Cancer Res., 65, 8174-8182.
24. Loeb, D.M., Korz, D., Katsnelson, M., Burwell, E.A., Friedman, A.D. and Sukumar, S. (2002) Cyclin E is a target of WT1 transcriptional repression. J. Biol. Chem., 277, 19627-19632.
25. Carpenter, B., Hill, K.J., Charalambous, M., Wagner, K.J., Lahiri, D., James, D.I., Andersen, J.S., Schumacher, V., Royer-Pokora, B., Mann, M., Ward, A. and Roberts, S.G. (2004) BASP1 is a transcriptional cosuppressor for the Wilms' tumor suppressor protein WT1. Mol. Cell. Biol., 24, 537-549.
26. Richard, D.J., Schumacher, V., Royer-Pokora, B. and Roberts, S.G. (2001) Par4 is a coactivator for a splice isoform-specific transcriptional activation domain in WT1. Genes Dev., 15, 328-339.
27. Matsuzawa-Watanabe, Y., Inoue, J. and Semba, K. (2003) Transcriptional activity of testis-determining factor SRY is modulated by the Wilms' tumor 1 gene product, WT1. Oncogene, 22, 7900-7904.
28. Wilhelm, D. and Englert, C. (2002) The Wilms tumor suppressor WT1 regulates early gonad development by activation of Sf1. Genes Dev., 16, 1839-1851.
29. Caricasole, A., Duarte, A., Larsson, S.H., Hastie, N.D., Little, M., Holmes, G., Todorov, I. and Ward, A. (1996) RNA binding by the Wilms tumor suppressor zinc finger proteins. Proc. Natl Acad. Sci. USA, 93, 7562-7566.
30. Duarte, A., Caricasole, A., Graham, C.F. and Ward, A. (1998) Wilms' tumour-suppressor protein isoforms have opposite effects on Igf2 expression in primary embryonic cells, independently of p53 genotype. Br. J. Cancer, 77, 253-259.
31. Laity, J.H., Dyson, H.J. and Wright, P.E. (2000) Molecular basis for modulation of biological function by alternate splicing of the Wilms' tumor suppressor protein. Proc. Natl Acad. Sci. USA., 97, 11932-11935.
32. Ladomery, M.R., Slight, J., Mc Ghee, S. and Hastie, N.D. (1999) Presence of WT1, the Wilm's tumor suppressor gene product, in nuclear poly(A)(+) ribonucleoprotein. J. Biol. Chem., 274, 36520-36526.
33. Spraggon, L., Dudnakova, T., Slight, J., Lustig-Yariv, O., Cotterell, J., Hastie, N. and Miles, C. (2006) hnRNP-U directly interacts with WT1 and modulates WT1 transcriptional activation. Oncogene, 26, 1484-1491.
34. Davies, R.C., Calvio, C., Bratt, E., Larsson, S.H., Lamond, A.I. and Hastie, N.D. (1998) WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes. Genes Dev., 12, 3217-3225.
35. Little, N.A., Hastie, N.D. and Davies, R.C. (2000) Identification of WTAP, a novel Wilms' tumour 1-associating protein. Hum. Mol. Genet., 9, 2231-2239.
36. Morrison, A.A., Venables, J.P., Dellaire, G. and Ladomery, M.R. (2006) The Wilms tumour suppressor protein WT1 (+KTS isoform) binds alpha-actinin 1 mRNA via its zinc-finger domain. Biochem. Cell Biol., 84, 789-798.
37. Morrison, A.A. and Ladomery, M.R. (2006) Presence of WT1 in nuclear messenger RNP particles in the human acute myeloid leukemia cell lines HL60 and K562. Cancer Lett., 244, 136-141.
38. Niksic, M., Slight, J., Sanford, J.R., Caceres, J.F. and Hastie, N.D. (2004) The Wilms' tumour protein (WT1) shuttles between nucleus and cytoplasm and is present in functional polysomes. Hum. Mol. Genet., 13, 463-471.
39. Dreyfuss, G., Kim, V.N. and Kataoka, N. (2002) Messenger-RNA-binding proteins and the messages they carry. Nat. Rev. Mol. Cell Biol., 3, 195-205.
40. Cesaro, E., De Cegli, R., Medugno, L., Florio, F., Grosso, M., Lupo, A., Izzo, P. and Costanzo, P. (2009) The Kruppel-like zinc finger protein ZNF224 recruits the arginine methyltransferase PRMT5 on the transcriptional repressor complex of the aldolase A gene. J. Biol. Chem., 284, 32321-32330.
41. Urrutia, R. (2003) KRAB-containing zinc finger repressor protein. Gen. Biol., 4, 231-238.
42. Huntley, S., Baggott, D.M., Hamilton, A.T., Tran-Gyamfi, M., Yang, S., Kim, J., Gordon, L., Branscomb, E. and Stubbs, L. (2006) A comprehensive catalog of human KRAB-associated zinc finger genes: insight into the evolutionary history of a large family of transcriptional repressors. Genome Res., 16, 669-677.
43. Hastie, N.D. (2001) Life, sex, and WT1 isoforms: three amino acids can make all the difference. Cell, 106, 391-394.
44. Aubry, M., Demczuk, S., Desmaze, C., Aikem, M., Aurias, A., Julien, J.P. and Rouleau, G.A. (1993) Isolation of a zinc finger gene consistently deleted in DiGeorge syndrome. Hum. Mol. Genet., 2, 1583-1587.
45. Ravassard, P., Côté, F., Grondin, B., Bazinet, M., Mallet, J. and Aubry, M. (1999) ZNF74, a gene deleted in DiGeorge syndrome, is expressed in human neural crest-derived tissues and foregut endoderm epithelia. Genomics, 62, 82-85.
46. Takase, K., Ohtsuki, T., Migita, O., Toru, M., Inada, T., Yamakawa-Kobayashi, K. and Arinami, T. (2001) Association of ZNF74 gene genotypes with age-at-onset of schizophrenia. Schizophr. Res., 52, 161-165.
47. Wagner, K.D., Wagner, N., Vidal, V.P., Schley, G., Wilhelm, D., Schedl, A., Englert, C. and Scholz, H. (2002) The Wilms' tumor gene Wt1 is required for normal development of the retina. EMBO J., 21, 1398-1405.
48. Wagner, N., Wagner, K.D., Hammes, A., Kirschner, K.M., Vidal, V.P., Schedl, A. and Scholz, H. (2005) A splice variant of the Wilms' tumour suppressor Wt1 is required for normal development of the olfactory system. Development, 132, 1327-1336.
49. Rosenfeld, C., Cheever, M.A. and Gaiger, A. (2003) WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapies. Leukemia, 17, 1301-1312.
50. Gemelli, C., Orlandi, C., Marani, T.Z., Martello, A., Vignudelli, T., Ferrari, F., Montanari, M., Parenti, S., Testa, A., Grande, A. and Ferrari, S. (2008) The vitamin D3/Hox-A10 pathway supports MafB function during the monocyte differentiation of human CD34+ hemopoietic progenitors. J. Immunol., 181, 5660-5672.
51. Chakrabarti, S.K., James, J.C. and Mirmira, R.G. (2002) Quantitative assessment of gene targeting in vitro and in vivo by the pancreatic transcription factor, Pdx1. Importance of chromatin structure in directing promoter binding. J. Biol. Chem., 277, 13286-13293.